Sana Biotechnology (SANA) Interest Coverage Ratio (2020 - 2026)
Sana Biotechnology (SANA) reported Interest Coverage Ratio of 0.43 for Q1 2026, down 40.42% on a YoY basis from 0.72 in Q1 2025, and up 100.0% sequentially from 61199.0 in Q4 2025.
Sana Biotechnology (SANA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Interest Coverage Ratio data on file, last reported at 0.43 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 40.42% year-over-year to 0.43; the trailing twelve-month figure through Mar 2026 stood at 2.18 (down 70.78% YoY), and the FY2025 full-year result was 2.1, up 40.33% from the prior year.
- Interest Coverage Ratio grew to 0.43 in Q1 2026, from 61199.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.01 in Q3 2023 to a low of 61199.0 in Q4 2025.
- A 5-year average of 3603.74 and a median of 0.59 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 98.98% in 2023 and plunged 177363.38% in 2025, its largest moves.
- Tracing SANA's Interest Coverage Ratio over 5 years: stood at 22.04 in 2022, then jumped by 98.98% to 0.23 in 2023, then plunged by 15223.35% to 34.49 in 2024, then sank by 177363.38% to 61199.0 in 2025, then soared by 100.0% to 0.43 in 2026.
- Business Quant data shows SANA's Interest Coverage Ratio at 0.43 in Q1 2026, 61199.0 in Q4 2025, and 1.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Sana Biotechnology | 888.71 Mn | 888.71 Mn | - | -0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.43 |
| Dec 31, 2025 | -61,199.00 |
| Sep 30, 2025 | -1.02 |
| Jun 30, 2025 | -0.73 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -34.49 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -1.29 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | -22.04 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -1.06 |
| Mar 31, 2022 | -0.18 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.49 |
| Jun 30, 2021 | 0.53 |